| Title |
Author |
Type |
Date |
Words |
| CMU-Q study sheds light on new possibilities in cancer therapy. |
|
|
Jul 12, 2021 |
598 |
| PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia. |
|
|
Jul 9, 2021 |
252 |
| Athenex announces update from FDA Type A meeting on oral paclitaxel. |
|
|
Jul 6, 2021 |
191 |
| Julie's plea for help to buy life-saving cancer drugs; Woman who raised [euro]10k for charity now seeking [euro]80k for own treatment. |
APRIL CURTIN |
|
Jun 25, 2021 |
534 |
| GSK, iTeos to develop cancer drug in up to $2 billion deal. |
Reuters News Service |
|
Jun 14, 2021 |
306 |
| Noxopharm accelerates towards Phase 2 trial for DARRT-2 study of anti-cancer drug VeyondaÃ. |
|
|
Jun 11, 2021 |
453 |
| Vicky battling paralysis as side effect of cancer drug; Blow for mum of two during US treatment. |
MARITA MOLONEY |
|
Jun 11, 2021 |
439 |
| $47m investment boost for anti-cancer drug firm. |
COREENA FORD Business writer coreena.ford@reachplc.com @Scoopford |
|
Jun 8, 2021 |
469 |
| Fate Therapeutics highlights interim data from phase 1 study of FT516, rituximab. |
|
|
Jun 4, 2021 |
508 |
| Athenex presents data on oral docetaxel, oral paclitaxel. |
|
|
Jun 4, 2021 |
268 |
| Breast cancer: Scientists hail 'major breakthrough' in breast cancer treatment; Scientists believe they have made a 'major breakthrough' in the treatment of breast cancer by using the targeted cancer drug olaparib after chemotherapy. |
Gary Flockhart |
|
Jun 4, 2021 |
596 |
| Noxopharm higher on independent trial data supporting Veyonda as major new anti-cancer drug. |
|
|
Jun 1, 2021 |
453 |
| Testing success for cancer drug. |
|
|
Jun 1, 2021 |
157 |
| Testing success for cancer drug. |
|
|
Jun 1, 2021 |
157 |
| A Case of Unclassified Renal Cell Carcinoma Initially Considered as Translocation RCC and Review of Literature. |
Karsiyakah, Nejdet; Ozgen, Mahir Bulent; Ozveren, Bora; Ekici, Isin Dogan; Turkeri, Levent |
Clinical report |
Jun 1, 2021 |
2222 |
| Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapies. |
Youn, Bora; Wilson, Ira B.; Mor, Vincent; Trikalinos, Nikolaos A.; Dahabreh, Issa J. |
Report |
Jun 1, 2021 |
6247 |
| Imugene believes it has found "the holy grail of cancer therapy". |
|
|
May 29, 2021 |
698 |
| Imugene believes it has found "the holy grail of cancer therapy". |
|
|
May 29, 2021 |
698 |
| NEWS BRIEFS. |
|
|
May 28, 2021 |
679 |
| TOP NEWS: AstraZeneca early-stage lung cancer drug gets EU approval. |
|
|
May 28, 2021 |
233 |
| LATEST COMPANY NEWS. |
|
|
May 25, 2021 |
27529 |
| Exelixis reports Phase 1b results from Cohort 6 of COSMIC-021 trial. |
|
Financial report |
May 24, 2021 |
224 |
| Regeneron, Sanofi land more European backing for Libtayo cancer drug. |
|
|
May 24, 2021 |
189 |
| An Unusual Presentation of Foreign Body Granuloma of Ankle Mimicking a Neoplastic Lesion. |
Dadlani, Mohit; Jaiswal, Ankit; Saoji, Kiran; Pisulkar, Gajanan |
|
May 17, 2021 |
1466 |
| Personalised cancer medicine centre opens in Sheffield; A newly built state-of-the-art pharmacy aseptic unit at Weston Park Cancer Centre has been officially unveiled at a socially distant ribbon-cutting ceremony today. |
|
|
May 15, 2021 |
294 |
| Hannah Named to Rigel Pharmaceuticals Board of Directors. |
|
|
May 14, 2021 |
521 |
| Cellectis, Sanofi enter supply, partnership agreement for alemtuzumab. |
|
|
May 11, 2021 |
186 |
| Cancer drug trial works wonders for nan Carol, 57. |
LEE GRIMSDITCH ECHO Reporter lee.grimsditch@reachplc.com @LeeGrimsditch |
|
May 11, 2021 |
443 |
| Three new medicines to treat cancer approved. |
|
|
May 11, 2021 |
208 |
| Dad told he has weeks to live as he awaits news of drug which could give him precious time for fundraiser; A loving dad who has been told he weeks to live in another devastating blow is hoping a compassionate scheme for a new cancer drug will give him precious time. |
Poppy Kennedy |
|
May 7, 2021 |
608 |
| TRACON Pharmaceuticals ends 1Q with $30.4M to fund its cancer drug trials. |
|
|
May 6, 2021 |
391 |
| Everest Medicines receives South Korean Orphan Drug Designation for breast cancer drug sacituzumab govitecan-hziy. |
|
|
May 6, 2021 |
152 |
| Everest Medicines receives South Korean Orphan Drug Designation for breast cancer drug sacituzumab govitecan-hziy. |
|
|
May 6, 2021 |
153 |
| Genprex initiates site recruitment for Acclaim-2 clinical trial for its lung cancer drug REQORSA. |
|
|
May 5, 2021 |
254 |
| Cytoreductive stereotactic body radiotherapy (SBRT) and combination SBRT with immune checkpoint inhibitors (ICIs) in metastatic renal cell carcinoma. |
Peng, Jonathan; Lalani, Aly-Khan; Swaminath, Anand |
Report |
May 4, 2021 |
4747 |
| Black individuals are woefully under-represented in clinical trials, in general, and in trials for cancer drugs, in particular. |
|
|
May 1, 2021 |
181 |
| Transcenta Holding doses first patient in phase one clinical study of gastric cancer drug. |
|
Clinical report |
Apr 19, 2021 |
191 |
| Transcenta Holding doses first patient in phase one clinical study of gastric cancer drug. |
|
Clinical report |
Apr 19, 2021 |
192 |
| Studies Suggest People with Blood Cancers May Not Be Optimally Protected after COVID-19 Vaccination. |
|
|
Apr 16, 2021 |
964 |
| Genprex presents positive preclinical data for lung cancer drug REQORSA at American Association for Cancer Research meeting. |
|
|
Apr 13, 2021 |
529 |
| Arix portfolio firm Artios Pharma to collaborate with Novartis on cancer therapy development. |
|
|
Apr 8, 2021 |
229 |
| LATEST COMPANY NEWS. |
|
|
Apr 6, 2021 |
25343 |
| Genprex to present preclinical data for lung cancer drug REQORSA at American Association for Cancer Research meeting. |
|
|
Mar 31, 2021 |
415 |
| Enrollment Complete in Phase 3 COSMIC-313 Pivotal Trial of Cabozantinib in Combination with Nivolumab and Ipilimumab Versus Nivolumab and Ipilimumab in Previously Untreated Advanced Renal Cell Carcinoma. |
|
|
Mar 31, 2021 |
541 |
| Clinical analysis of 125I seed implantation combined with Apatinib in the treatment of locally advanced lung cancer: A case series. |
Yiling Feng; Bo Yang; Xiaoping Li |
Clinical report |
Mar 31, 2021 |
1496 |
| WCM-Q Grand Rounds to focus on cancer therapies, Alzheimer's and data sharing in pandemics. |
|
|
Mar 25, 2021 |
405 |
| Incyte's Pemazyre Approved in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cancer Chemotherapy. |
|
|
Mar 24, 2021 |
847 |
| Faron Pharma says trial on precision cancer drug shows significant efficacy signals. |
|
|
Mar 23, 2021 |
438 |
| Faron Pharma says trial on precision cancer drug shows significant efficacy signals. |
|
|
Mar 23, 2021 |
438 |
| Faron Pharmaceuticals shares boosted by positive data on cancer drug. |
|
|
Mar 22, 2021 |
263 |
| LATEST COMPANY NEWS. |
|
|
Mar 16, 2021 |
25120 |
| MD Anderson's Therapeutics Discovery Division, Orionis Biosciences Launch Project Helios to Advance Novel Small-Molecule Cancer Medicines. |
|
|
Mar 10, 2021 |
315 |
| Genome and Company partners with Merck, Pfizer on anti-cancer drug. |
|
|
Mar 9, 2021 |
228 |
| Chemotoxicity in Carcinoma Breast Patients--Its Incidence and Trends in Severity--An Observational Study. |
Yeola, Meenakshi Eknath; Borgaonkar, Aditya Prabhakar Rao |
|
Mar 8, 2021 |
4115 |
| Highlight Therapeutics starts recruiting for metastatic melanoma drug trial. |
|
|
Mar 3, 2021 |
360 |
| Kazia Therapeutics grants Oasmia exclusive rights for first-in-class ovarian cancer drug candidate Cantrixil. |
|
|
Mar 2, 2021 |
573 |
| Kazia Therapeutics grants Oasmia exclusive rights for first-in-class ovarian cancer drug candidate Cantrixil. |
|
|
Mar 2, 2021 |
571 |
| LATEST COMPANY NEWS. |
|
|
Mar 1, 2021 |
24427 |
| Progress Toward Leukemia Drug Therapy. |
|
|
Mar 1, 2021 |
306 |
| Changes in Metastatic Castration Sensitive Prostate Cancer. |
Gurbuz, Mustafa; Urun, Yuksel |
Disease/Disorder overview |
Mar 1, 2021 |
4989 |
| What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment? |
Tokmak, Salih; Gumurdulu, Yuksel; Tas, Didem A.; Kara, Ibrahim O.; Guzel, Ahmet B. |
|
Mar 1, 2021 |
4233 |
| What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment? |
Tokmak, Salih; Gumurdulu, Yuksel; Tas, Didem A.; Kara, Ibrahim O.; Guzel, Ahmet B. |
Report |
Mar 1, 2021 |
4369 |
| Practice guide for cytotoxic drugs. |
|
|
Mar 1, 2021 |
167 |
| Reconstructing an ovary cancer microenvironment for in vitro 3D drug testing: A new avenue for ovary cancer research. |
Antarianto, Radiana Dhewayani; Khaerunnisa, Sanya; Pangjaya, Lady Feren; Lubis, Dinda Shezaria Hardy |
Report |
Feb 28, 2021 |
2923 |
| Nutritional medical therapy in cachexia patient with oesophageal adenocarcinoma metastases on dexamethasone therapy: A case report. |
Stefani, Shiela; Andayani, Diyah Eka |
Clinical report |
Feb 28, 2021 |
1661 |
| Short Communication - The Effect of Kanglaite Injection on Apoptosis of Colon Cancer SW480 Cells and Expression of Apoptosis-Related Factors. |
Zhao, Yujun; Fan, Jianping |
Report |
Feb 24, 2021 |
2137 |
| AstraZeneca withdraws bladder cancer drug in US. |
|
|
Feb 23, 2021 |
308 |
| Potential seen for Takeda lung cancer treatment. |
|
|
Feb 15, 2021 |
537 |
| Opdivo, Cabometyx Combination Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma in the Phase 3 CheckMate -9ER Trial. |
|
|
Feb 10, 2021 |
957 |
| 4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug. |
|
|
Feb 8, 2021 |
245 |
| InnoCare Wins China Approval of Orelabrutinib in Combination with R-CHOP as First-Line Therapy for Mantle Cell Lymphoma. |
|
|
Feb 5, 2021 |
306 |
| Experimental cancer pill could fight COVID-19: UK scientists. |
Arab News |
|
Feb 3, 2021 |
182 |
| HIGH BCR-ABL1 GENE PERCENTAGE AT TIME OF PRESENTATION: A TOOL TO PREDICT FAILURE IN ACHIEVING EARLY MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): A TERTIARY CARE CENTER EXPERIENCE. |
Amjad Khan, Riaz Ahmed, Sarah Fatimah, Muhammad Nadeem, Shama Iqbal, Sayed Tanveer Abbas Gilani and |
|
Jan 31, 2021 |
2494 |
| Blood cancer drug boost for patients. |
IAN JOHNSON Reporter ian.johnson@reachplc.com |
|
Jan 28, 2021 |
486 |
| Life-changing cancer drug now made available on NHS; TREATMENT CAN EXTEND LIVES OF BLOOD CANCER SUFFERERS FOR YEARS. |
IAN JOHNSON Reporter ian.johnson01@reachplc.com @IANJOHNSONCHRON |
|
Jan 28, 2021 |
549 |
| Evgen Pharma updates on the +STAR' trial for Covid-19, Glioma research and key breast cancer drug. |
|
|
Jan 26, 2021 |
159 |
| MorphoSys, I-Mab Dose First Patient In Phase One Study Of Cancer Drug. |
|
|
Jan 26, 2021 |
223 |
| Evgen Pharma CEO hails pre-clinical data from lead drug in glioma and glioblastoma models. |
|
|
Jan 22, 2021 |
283 |
| Takeda Pharmaceutical Gets Japan Green Light For Lung Cancer Drug. |
|
|
Jan 22, 2021 |
170 |
| AstraZeneca says EU approves breast cancer drug. |
|
|
Jan 21, 2021 |
311 |
| TRACON says cancer drug envafolimab gets priority review from Chinese regulators, according to corporate partners. |
|
|
Jan 20, 2021 |
396 |
| AstraZeneca receives US approval for stomach cancer drug. |
|
|
Jan 19, 2021 |
338 |
| TOP NEWS: AstraZeneca Says Gastric Cancer Drug Enhertu Approved In US. |
|
|
Jan 18, 2021 |
191 |
| AstraZeneca says EU, UK approve cancer drug for additional dosing option. |
|
|
Jan 16, 2021 |
336 |
| EU Okays New Dosing Option For Lung Cancer Drug Imfinzi - AstraZeneca. |
|
|
Jan 15, 2021 |
225 |
| Genprex meets manufacturing requirements for lung cancer drug REQORSA ahead of combination trials. |
|
|
Jan 14, 2021 |
372 |
| MaxCyte inks licensing deal with Myeloid Therapeutics to advance cancer therapies. |
|
|
Jan 12, 2021 |
310 |
| Denovo Biopharma doses first patient in biomarker guided Phase three clinical study of DB102 in combination with temozolomide and radiation. |
|
Clinical report |
Jan 11, 2021 |
258 |
| Denovo Biopharma doses first patient in biomarker guided Phase three clinical study of DB102 in combination with temozolomide and radiation. |
|
Clinical report |
Jan 11, 2021 |
262 |
| CARDIOPROTECTIVE ACTIVITIES OF QUERCETIN AND RUTIN IN SPRAGUE DAWLEY RATS TREATED WITH 5-FLUOROURACIL. |
E. Sengul, V. Gelen and S. Gedikli |
|
Jan 5, 2021 |
4989 |
| Transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma: response analysis with mRECIST. |
Domaratius, Claudia; Settmacher, Utz; Malessa, Christina; Teichgraber, Ulf |
Report |
Jan 1, 2021 |
5301 |
| Efficacy and Safety of Bevacizumab-Combined Chemotherapy for Advanced and Recurrent Endometrial Cancer: A Systematic Review and Meta-analysis. |
Chen, Hui; Liang, Minglin; Min, Jie |
Report |
Jan 1, 2021 |
4135 |
| ALTERED APOPTOTIC PROTEIN EXPRESSIONS CHARACTERIZE THE SURVIVAL OF BCR-ABL-INDEPENDENT DRUG-RESISTANT CHRONIC MYELOID LEUKEMIA CELL LINE. |
Baykal-Kose, Seda; Yalcin, Pelin |
|
Jan 1, 2021 |
2406 |
| Clinically-targetable vulnerabilities in cancer metabolism: A systematic review and meta-analysis. |
Javaeed, Arslaan; Ghauri, Sanniya Khan |
Report |
Dec 31, 2020 |
8016 |
| Bristol-Myers Squibb Withdraws Lung Cancer Drug Opdivo As Study Fails. |
|
|
Dec 30, 2020 |
288 |
| AstraZeneca lung cancer drug receives US regulatory green light. |
|
|
Dec 22, 2020 |
273 |
| Roche's Covid Antibody Test Approved In US Along With Cancer Drug. |
|
|
Dec 2, 2020 |
536 |
| HER2 Dual In Situ Hybridization: Correlations and Cautions. |
Troxell, Megan; Sibley, Richard K.; West, Robert B.; Bean, Gregory R.; Allison, Kimberly H. |
Report |
Dec 1, 2020 |
5550 |
| Mycosis Fungoides in Puerto Rico: A 15-year Follow-up Retrospective Study. |
Arias-Berrios, Gabriel E.; Falto-Aizpurua, Leyre; Figueroa-Guzman, Luz |
|
Dec 1, 2020 |
3343 |
| Interaction of curcumin on cisplatin cytotoxicity in HeLa and HepG2 carcinoma cells. |
Becit, Merve; Dilsiz, Sevtap Aydin; Basaran, Nursen |
|
Dec 1, 2020 |
6509 |
| Interaction of curcumin on cisplatin cytotoxicity in HeLa and HepG2 carcinoma cells. |
Becit, Merve; Dilsiz, Sevtap Aydin; Basaran, Nursen |
|
Dec 1, 2020 |
7010 |
| Thoughts at Large: Controversies in Clinical Nutrition and Functional Medicine: Issue #18 NUTRITIONAL SUPPORT FOR CANCER PATIENTS. |
Moss, Jeffrey |
|
Dec 1, 2020 |
3028 |
| Attack on fiancee broke two fingers; FRIGHTENED VICTIM WAS GETTING CANCER THERAPY, COURT TOLD. |
DAVID POWELL Daily Post Reporter david.powell@reachplc.com |
|
Nov 13, 2020 |
424 |
| OncoMyx Therapeutics Names Baum as Chairperson of Its Board of Directors. |
|
|
Nov 6, 2020 |
375 |
| Humanigen to present abstract covering a lymphoma study of its drug lenzilumab at hematology conference. |
|
Conference news |
Nov 5, 2020 |
303 |
| MEDULLARY THYROID CANCER--FEATURE REVIEW AND UPDATE ON SYSTEMIC TREATMENT/MEDULARNI KARCINOM STITNJACE--PREGLED ZNACAJKI I NOVOSTI U SUSTAVNOM LIJECENJU. |
Dabelic, Nina; Jukic, Tomislav; Frobe, Ana |
Disease/Disorder overview |
Nov 1, 2020 |
6304 |
| KINASE INHIBITORS IN THE TREATMENT OF THYROID CANCER: INSTITUTIONAL EXPERIENCE/PRIMJENA INHIBITORA KINAZA U LIJECENJU BOLESNIKA S UZNAPREDOVALIM RAKOM STITNJACE. |
Pesorda, Matea; Kuna, Sanja Kusacic; Huic, Drazen; Herceg, Davorin; Despot, Marija; Samardzic, Tatja |
Report |
Nov 1, 2020 |
4379 |
| Validation of a pan-cancer targeted next generation sequencing panel in New Zealand. |
Wilson, Andrew D.; Brown, Angela E.; Turner, Claire; Zamanpoor, Mansour; Felix, Clive A.; Thunders, |
|
Nov 1, 2020 |
3911 |
| Daiichi Sankyo doses first patient in cancer drug DS-1055 study. |
|
|
Oct 23, 2020 |
194 |
| Daiichi Sankyo doses first patient in cancer drug DS-1055 study. |
|
|
Oct 23, 2020 |
198 |
| Sandoz, ECS to produce biosimilar for blood cancer medication. |
Daily News Egypt |
|
Oct 21, 2020 |
557 |
| European CHMP Adopts Positive Opinion for Kite's KTE-X19 for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma. |
|
|
Oct 20, 2020 |
523 |
| AstraZeneca's Tagrisso Gets Priority Review In US As Lung Cancer Drug. |
|
|
Oct 20, 2020 |
237 |
| NHIA adds anti-Breast Cancer drug (Herceptin) to Ghana's NHIS Medicine list. |
|
|
Oct 10, 2020 |
1145 |
| How SEiRSE Technology is breaking the next frontier to test a cannabinoid-based cancer therapy. |
|
|
Oct 3, 2020 |
1493 |
| BRUKINSA RECEIVES ACCEPTANCE AND PRIORITY REVIEW. |
|
|
Oct 1, 2020 |
796 |
| Breast Cancer: The Latest News in Risk Prediction and Treatment: Gene profiling helps predict the risk of recurrence, and newer drugs help women with advanced-stage cancer live longer. |
|
|
Oct 1, 2020 |
964 |
| Formulation and In Vitro Evaluation of Telmisartan Nanoparticles Prepared by Emulsion-Solvent Evaporation Technique/Emulsiyon-Cozucu Buharlastirma Teknigi ile Hazirlanan Telmisartan Nanopartikullerinin Formulasyonu ve In Vitro Degerlendirilmesi. |
Ozturk, Naile; Kara, Asli; Vural, Imran |
Report |
Oct 1, 2020 |
5475 |
| Aureolic Acid Group of Agents as Potential Antituberculosis Drugs. |
Bespyatykh, Julia; Bespiatykh, Dmitry; Malakhova, Maja; Klimina, Ksenia; Bespyatykh, Andrey; Varizhu |
Clinical report |
Oct 1, 2020 |
6533 |
| UA Trustees OK Ventures to Offer Cancer Therapy. |
|
|
Sep 28, 2020 |
241 |
| Thailand to start producing all types of cancer drugs soon. |
|
|
Sep 25, 2020 |
342 |
| Nuformix grants six month option over cancer drug candidate. |
|
|
Sep 25, 2020 |
319 |
| LIPAC Oncology completes LiPax (paclitaxel) Phase 2A marker lesion clinical trial. |
|
|
Sep 9, 2020 |
154 |
| Hutchison China MediTech starts late-stage trial on colorectal cancer drug. |
|
|
Sep 5, 2020 |
188 |
| Hutchison China MediTech starts late-stage trial on colorectal cancer drug. |
|
|
Sep 5, 2020 |
186 |
| Risk of Neoplastic Squall Downstream Cytokine Storm of COVID-19 in Male Patients. |
Turkeri, Levent; Ovall, Ercument |
|
Sep 1, 2020 |
1026 |
| Management of Patients with Urological Cancers in Turkey during the COVID-19 Pandemic: Recommendations of Uro-oncology Association. |
Celik, Serdar; Tlnay, Ilker; Narter, Fehmi; Eskicorapci, Saadettin; Ataus, Suleyman; Turkeri, Levent |
|
Sep 1, 2020 |
3067 |
| Antimicrobial, Antioxidant, and Antiproliferative Effects of Coronilla minima: An Unexplored Botanical Species. |
Ferrante, Claudio; Angelini, Paola; Venanzoni, Roberto; Flores, Giancarlo Angeles; Tirillini, Bruno; |
Report |
Sep 1, 2020 |
5461 |
| Figainin 1, a Novel Amphibian Skin Peptide with Antimicrobial and Antiproliferative Properties. |
Santana, Carlos Jose Correia; Magalhaes, Ana Carolina Martins; Junior, Agenor C. M. dos Santos; Rica |
Report |
Sep 1, 2020 |
6376 |
| Repositioning of Metformin: Anticancer Agent for Hypoxic Neuroblastoma Cells. |
Surer, Seniz Inanc; Toksoz, Feriha; Bayrak, Serdar; Meco, Hanife Ecenur; Sever, Tolga; Basbinar, Yas |
|
Sep 1, 2020 |
3386 |
| OCCUPATIONAL EXPOSURE TO ANTINEOPLASTIC DRUGS IN HOSPITAL ENVIRONMENTS: POTENTIAL RISK ASSOCIATED WITH CONTACT WITH CYCLOPHOSPHAMIDEAND IFOSFAMIDE-CONTAMINATED SURFACES. |
Mucci, Nicola; Dugheri, Stefano; Farioli, Andrea; Garzaro, Giacomo; Rapisarda, Venerando; Campagna, |
Report |
Sep 1, 2020 |
5738 |
| In-silico Analysis to Determine the Efficient Drug for Malignant Melanoma using Molecular Dynamics. |
Pallavi, M.S.; Kumar, H.S. Pramod |
Report |
Sep 1, 2020 |
2391 |
| Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Carcinoma: A Real-World Study. |
Zhang, Mengmeng; Li, Ling; Zhang, Shiyong; Zhu, Wenlong; Yang, Senguo; Di, Guangsheng; Ma, Xiaoxia; |
Report |
Aug 31, 2020 |
5592 |
| 3D-QSAR Study of the Chalcone Derivatives as Anticancer Agents. |
ElMchichi, Larbi; Belhassan, Assia; Lakhlifi, Tahar; Bouachrine, Mohammed |
Report |
Aug 31, 2020 |
6399 |
| Metastatic Syringocystadenocarcinoma Papilliferum: A Case Report, Tumor Genomic Profiling, and Literature Review. |
Altunel, Erdem; Perepletchikov, Aleksandr; Kozyreva, Olga |
|
Aug 31, 2020 |
1740 |
| Synthesis and Biological Evaluation of Novel 4-Phenylaminobenzofuro[2,3-d]pyrimidine Derivatives. |
Ju liu, Jun Li, Jian-tao Shi, Jie Li, Xue-chen Hao, Duang-zheng Song, Yang Wang, Shi Ding and Ye Che |
|
Aug 31, 2020 |
4481 |
| AstraZeneca says Imfinzi approved as lung cancer drug combination in Japan. |
|
|
Aug 22, 2020 |
267 |
| Clinical effect of decitabine in the treatment of myelodysplastic syndrome and influencing factors. |
Tangxia Liu, Jing Wang, Chunmei Li and Lingzhi Jia |
|
Aug 8, 2020 |
3194 |
| Philhealth chief Morales told to go on leave due to lymphoma, chemotherapy. |
|
|
Aug 8, 2020 |
300 |
| GlaxoSmithKline receives green light for bone marrow cancer drug. |
|
|
Aug 7, 2020 |
248 |
| Roche Secures European Approval For Rozlytrek Cancer Drug. |
|
|
Aug 3, 2020 |
165 |
| Cancer Immunotherapy in Solid Organ Transplanted Patients/Solid-Organ Transplantasyonu Olan Hastalarda Kanser Immunoterapisi. |
Abdi, Ali; Oktelik, Fatma Betul; Bicer, Mehtap Dogruel; Gurol, Ali Osman |
|
Aug 1, 2020 |
5719 |
| Huaier Granule Combined with Tegafur Gimeracil Oteracil Potassium Promotes Stage IIb Gastric Cancer Prognosis and Induces Gastric Cancer Cell Apoptosis by Regulating Livin. |
Qi, Jing; Xie, Fu-juan; Liu, Sheng; Yao, Cheng-yu; Liu, Wei-hang; Cai, Gao-qiang; Liao, Guo-qing |
Report |
Jul 31, 2020 |
5376 |
| The Occurrence of Richter's Syndrome during Treatment with Obinutuzumab and Chlorambucil. |
Ng, Teng Fong; Carnley, Benedict; Green, Celia; Spagnolo, Dominic; Leahy, Michael F. |
|
Jul 31, 2020 |
2614 |
| Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review. |
Gong, Yingbo; Wang, Xin; Zhu, Zhi |
|
Jul 31, 2020 |
3752 |
| Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer. |
Kawagoe, Tetsuro; Ikeda, Go; Oshiro, Yu; Maruki, Yuta; Kaneko, Keiko; Iwakiri, Katsuhiko |
|
Jul 31, 2020 |
2171 |
| Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy. |
Myrdal, Caitlyn N.; Sundararajan, Srinath |
|
Jul 31, 2020 |
3179 |
| Malignant Gastrointestinal Neuroectodermal Tumor (GNET) with Prolonged Disease-Free Survival after Platinum-Based Chemotherapy. |
Singh, Daulath; Atieh, Mohammed K.; Russell, Mark A.; Kittaneh, Muaiad |
|
Jul 31, 2020 |
2880 |
| Roche In US Breakthrough Status For Cancer Drug; Teams With Blueprint. |
|
|
Jul 14, 2020 |
374 |
| Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin. |
|
|
Jul 13, 2020 |
212 |
| Breast cancer medication breakthrough. |
|
|
Jul 7, 2020 |
160 |
| Daiichi Sankyo Company reports EMA's accelerated assessment for trastuzumab feruxtecan for HER2 positive metastatic breast cancer. |
|
|
Jul 6, 2020 |
258 |
| Daiichi Sankyo Company reports EMA's accelerated assessment for trastuzumab feruxtecan for HER2 positive metastatic breast cancer. |
|
|
Jul 6, 2020 |
254 |
| The expanding role of biomarker testing in non-small cell lung cancer. |
Vennapusa, Bharathi |
|
Jul 1, 2020 |
1948 |
| Molecular Targeted Cancer Therapies and the Kidney. |
Aksu, Ozge Bas; Sadioglu, Rezzan Eren; Sengul, Sule |
|
Jul 1, 2020 |
6275 |
| Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma. |
Berlow, Noah E.; Grasso, Catherine S.; Quist, Michael J.; Cheng, Mingshan; Gandour-Edwards, Regina; |
|
Jun 30, 2020 |
6935 |
| Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met. |
Hyuga, Sumiko; Hyuga, Masashi; Amakura, Yoshiaki; Yang, Jinwei; Mori, Eiko; Hakamatsuka, Takashi; Go |
|
Jun 30, 2020 |
8398 |
| Limitations of Systemic Oncological Therapy in Breast Cancer Patients with Chronic Kidney Disease. |
Bednarek, Anna; Mykala-Ciesla, Joanna; Pogoda, Katarzyna; Jagiello-Gruszfeld, Agnieszka; Kunkiel, Mi |
|
Jun 30, 2020 |
8748 |
| Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis. |
Mikhaylenko, Dmitry S.; Tanas, Alexander S.; Zaletaev, Dmitry V.; Nemtsova, Marina V. |
|
Jun 30, 2020 |
10369 |
| Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment. |
Roviello, Giandomenico; Casadei-Gardini, Andrea; Nobili, Stefania; Mini, Enrico; Fancelli, Sara |
|
Jun 30, 2020 |
2525 |
| Proapoptotic and Antiangiogenic Activities of Arctium Lappa L. on Breast Cancer Cell Lines. |
Agha, Mohamad Taleb; Baharetha, Hussein M.; Al-Mansoub, Majed Ahmed; Tabana, Yasser M.; Aziz, Nur Hi |
|
Jun 30, 2020 |
9395 |
| Merck KGaA, Pfizer Complete Bladder Cancer Drug Application In Europe. |
|
|
Jun 22, 2020 |
175 |
| Revolution Medicines gives R&D update on novel targeted cancer therapies. |
|
|
Jun 22, 2020 |
173 |
| New cancer drug created; Health: Aberdeen University scientists in pioneering work to tackle disease. |
NEIL DRYSDALE |
|
Jun 20, 2020 |
423 |
| Genprex ramps up production of active agent for its lung cancer drug Oncoprex. |
|
|
Jun 17, 2020 |
335 |
| Experimental Cancer Drug May Treat Devastating Genetic Illness. |
|
|
Jun 15, 2020 |
242 |
| Alphamab Oncology partners with Sanofi for studying Taxotere and KN026 combination in treating HER2+ breast cancer. |
|
|
Jun 9, 2020 |
238 |
| Alphamab Oncology partners with Sanofi for studying Taxotere and KN026 combination in treating HER2+ breast cancer. |
|
|
Jun 9, 2020 |
234 |
| YouTube vlogger Emman Nimedez begins chemotherapy for leukemia. |
|
|
Jun 3, 2020 |
375 |
| Development of Trimethoprim Drug and Innovation of Sulfazane-Trimethoprim Derivatives as Anticancer Agents. |
Aljamali, Nagham Mahmood; Kareem, Imad; Alsabri, Alwan |
Report |
Jun 1, 2020 |
4451 |
| Full Validation of the Method Employed to Analyze Oxycodone and Imatinib with LC-MS Using Monte-Carlo Simulation. |
Hamedane, O. Alami; Saffaj, T.; Ihssane, B.; Hajji, R. El; Jhilal, F.; Benchekroun, Y. Hameda; Sosse |
Report |
Jun 1, 2020 |
4360 |
| Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro. |
Stolte, Maximilian; Ali, Weaam; Janis, Janne; Gessner, Andre'; Najjar, Nahed El- |
Report |
Jun 1, 2020 |
10728 |
| Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies. |
Robles-Planells, Claudia; Sanchez-Guerrero, Giselle; Barrera-Avalos, Carlos; Matiacevich, Silvia; Ro |
|
May 31, 2020 |
6711 |
| Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course. |
McLigeyo, Angela; Rajab, Jamilla; Ezzi, Mohammed; Oyiro, Peter; Bett, Yatich; Odhiambo, Andrew; Ongo |
|
May 31, 2020 |
3132 |
| Using Topomer Comparative Molecular Field Analysis to Elucidate Activity Differences of Aminomethylenethiophene Derivatives as Lysyl Oxidase Inhibitors: Implications for Rational Design of Antimetastatic Agents for Cancer Therapy. |
Han, Jing; Yan, Guochao; Feng, Jianping; Yang, Xianglin; Zhou, Yuan |
|
May 31, 2020 |
3387 |
| Syncona says investee firm starts trials for new +personalised' skin cancer therapy. |
|
|
May 30, 2020 |
300 |
| WCM-Q scientists modify bacteria cells to deliver anti-cancer drugs. |
|
|
May 29, 2020 |
572 |
| Syncona Investee Achilles Therapeutics Starts Melanoma Therapy Trial. |
|
|
May 29, 2020 |
281 |
| Iovance presents data for TIL therapy lifileucel in advanced melanoma at ASCO. |
|
|
May 29, 2020 |
241 |
| WCM-Q researchers help reprogram bacteria cells to deliver anti-cancer drugs. |
|
|
May 28, 2020 |
638 |
| Prostate cancer: Breast cancer drug olaparib has the potential to be the world's first precision medicine for prostate cancer, writes Amy Packer. |
Amy Packer |
|
May 26, 2020 |
1142 |
| PROSTATE CANCER: the new hope; Breast cancer drug olaparib has the potential to be the world's first precision medicine for prostate cancer, writes. |
AMY PACKER |
|
May 26, 2020 |
1156 |
| Current Approach to Neutropenic Enterocolitis. |
Erturk, Umran Sumeyse; Turak, Esra Ermis; Kaynar, Leylagul; Fadel, Elias |
|
May 21, 2020 |
1352 |
| Appeal trial for fake cancer drugs case at VN Pharma starts. |
|
|
May 18, 2020 |
445 |
| US FDA approves NJ Novartis Pharmaceuticals' Tabrecta lung cancer drug. |
|
|
May 7, 2020 |
233 |
| US FDA approves NJ Novartis Pharmaceuticals' Tabrecta lung cancer drug. |
|
|
May 7, 2020 |
237 |
| Rising Pharmaceuticals, Laurus Labs to Support a Phase 2 Randomized Clinical Trial of Hydroxychloroquine for Prophylaxis Against COVID-19 in Patients Receiving Cancer Therapy. |
|
|
May 7, 2020 |
385 |
| Current Approaches for Personalized Therapy of Soft Tissue Sarcomas. |
Kirsanov, Kirill I.; Lesovaya, Ekaterina A.; Fetisov, Timur I.; Bokhyan, Beniamin Yu; Belitsky, Genn |
|
Apr 30, 2020 |
11703 |
| A Case Report with Severe Thrombocytopenia Induced by Axitinib. |
Koksal, Ulkuhan I.; Goffin, Janeiro Valle; Lewis, Brian; Sartor, Oliver A.; Belyaeva, Elizaveta; Soc |
|
Apr 30, 2020 |
2568 |
| A Case of Cardiac Tamponade in a Patient with Metastatic Renal Cell Carcinoma on Pazopanib Treatment. |
Sarathy, Vinu; Jayappa, Sriniivas Belagutty; Waran, Thianesh; Naik, Radheshyam |
|
Apr 30, 2020 |
1486 |
| Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice. |
Xue, Jing; Cheng, Yu; Hao, Haojie; Gao, Jieqing; Yin, Yaqi; Yu, Songyan; Zou, Junyan; Liu, Jiejie; Z |
|
Apr 30, 2020 |
8362 |
| ctDNA Detection in Microfluidic Platform: A Promising Biomarker for Personalized Cancer Chemotherapy. |
Gauri, Samla; Ahmad, Mohd R. |
|
Apr 30, 2020 |
6908 |
| Pharmaxis cancer drug ready to start myelofibrosis phase 2 studies this year. |
|
|
Apr 29, 2020 |
740 |
| Experimental cancer drug could stop coronavirus in its tracks, scientists claim; Scientists from the University of Louisville have developed a technology that they believe could stop the virus from infecting human cells. |
By, Shivali Best |
|
Apr 27, 2020 |
273 |
| CNS Pharmaceuticals Files for FDA Orphan Drug Designation for Brain Cancer Drug Berubicin. |
|
|
Apr 27, 2020 |
444 |
| AstraZeneca cancer drug passes prostate trial milestone. |
|
|
Apr 25, 2020 |
221 |
| TRACON Pharmaceuticals retains rights to prostate cancer drug candidate, targets China for commercialization. |
|
|
Apr 25, 2020 |
474 |
| Keeping active is the best prostate cancer medicine. |
DR MIRIAM STOPPARD |
|
Apr 21, 2020 |
452 |
| Potential cancer drug in willows. |
|
|
Apr 16, 2020 |
168 |
| Potential cancer drug in willows. |
|
|
Apr 16, 2020 |
168 |
| AstraZenecaAato trial blood cancer drug for coronavirus treatment. |
|
|
Apr 15, 2020 |
440 |
| AstraZenecaAato trial blood cancer drug for coronavirus treatment. |
|
|
Apr 15, 2020 |
442 |
| Cancer drug could protect people from worst effects of Covid-19; A global clinical trial will now be launched into the power of Calquence. |
By, Neil Shaw |
|
Apr 14, 2020 |
164 |
| Examining the Early Period Effect of Nilotinib on Hearing: An Experimental Study. |
Bora, Adem; Durmus, Kasim; Terzi, Hatice; Altuntas, Emine Elif |
Report |
Apr 1, 2020 |
7853 |
| Giant Primary Retroperitoneal Serous Cystadenoma: A Rare Entity Mimicking Multiple Neoplastic and Nonneoplastic Processes. |
Chen, Fengming; Jiang, Kun |
|
Apr 1, 2020 |
3527 |
| Neoplastic patients' knowledge about intestinal parasitoses in southern Brazil/Conhecimento de pacientes neoplasicos sobre parasitoses intestinais no sul do Brasil. |
Jeske, S.; Bianchi, T.F.; Leon, I.F.; Villela, M.M. |
|
Apr 1, 2020 |
5580 |
| High Hydrostatic Pressure Therapy Annihilates Squamous Cell Carcinoma in a Murine Model. |
Mitsui, Toshihito; Morimoto, Naoki; Mahara, Atsushi; Notodihardjo, Sharon Claudia; Le, Tien Minh; Mu |
|
Mar 31, 2020 |
4893 |
| Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation. |
Seo, Takuji; Noguchi, Emi; Yoshida, Masayuki; Mori, Taisuke; Tanioka, Maki; Sudo, Kazuki; Shimomura, |
|
Mar 31, 2020 |
3133 |
| Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/ Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review. |
Parrondo, Ricardo D.; Roy, Vivek; Sher, Taimur; Alegria, Victoria; Chanan-Khan, Asher A.; Ailawadhi, |
|
Mar 31, 2020 |
3985 |
| Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
Yu, Liuwen; Fu, Fangmeng; Li, Jing; Huang, Meng; Zeng, Bangwei; Lin, Yuxiang; Mei, Qian; Lv, Jinxing |
|
Mar 31, 2020 |
9224 |
| Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer. |
Gaibar, Maria; Beltran, Laura; Romero-Lorca, Alicia; Fernandez-Santander, Ana; Novillo, Apolonia |
|
Mar 31, 2020 |
9336 |
| Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy. |
Bilska, Monika; Pawlowska, Anna; Zakrzewska, Ewelina; Chudzik, Agata; Suszczyk, Dorota; Gogacz, Mare |
|
Mar 31, 2020 |
9245 |
| Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community Practices. |
Nadler, Eric; Aguilar, Kathleen; Wentworth, Chuck; Boyd, Marley; Amirian, E. Susan; Barker, Scott; F |
Clinical report |
Mar 31, 2020 |
7452 |
| Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma. |
Bucklein, Veit; Limmroth, Christina; Kampmann, Eric; Schuebbe, Gesa; Issels, Rolf; Roeder, Falk; Ang |
|
Mar 31, 2020 |
6140 |
| Homology Modeling and Virtual Screening Studies of Antigen MLAA-42 Protein: Identification of Novel Drug Candidates against Leukemia--An In Silico Approach. |
Shehadi, Ihsan A.; Rashdan, Huda R.M.; Abdelmonsef, Aboubakr H. |
|
Mar 31, 2020 |
5664 |
| Exelixis says Takeda Pharmaceutical receives approval in Japan for CABOMETYX. |
|
|
Mar 25, 2020 |
321 |
| Exelixis Partner Takeda Receives Approval in Japan for Cabometyx Tablets for the Treatment of Curatively Unresectable or Metastatic Renal Cell Carcinoma. |
|
|
Mar 25, 2020 |
649 |
| New i Data On Ex-V vo FC21 Expanded NKCell Therapy In 13 Leukemia Patients. |
|
|
Mar 23, 2020 |
316 |
| Breast Cancer Drugs may Severely Inflame lungs, the FDA Warns. |
|
|
Mar 22, 2020 |
176 |
| African American Men with Advanced Prostate Cancer Treated with Provenge Live Longer than Caucasian Men, Study Shows. |
|
|
Mar 18, 2020 |
649 |
| InxMed (Shanghai) doses first patient in Phase Ib clinical trial of cancer drug IN10018. |
|
|
Mar 17, 2020 |
203 |
| InxMed (Shanghai) doses first patient in Phase Ib clinical trial of cancer drug IN10018. |
|
|
Mar 17, 2020 |
199 |
| AstraZeneca provides update on phase III GY004 trial for cediranib in platinum-sensitive relapsed ovarian cancer. |
|
|
Mar 13, 2020 |
478 |
| AstraZeneca provides update on phase III GY004 trial for cediranib in platinum-sensitive relapsed ovarian cancer. |
|
|
Mar 13, 2020 |
479 |
| AstraZeneca provides update on phase III GY004 trial for cediranib in platinum-sensitive relapsed ovarian cancer. |
|
|
Mar 13, 2020 |
474 |
| AstraZeneca's Lynparza, Cediranib Trial Fails To Meet Primary Endpoint. |
|
|
Mar 12, 2020 |
206 |
| Phase 3 GY004 for Cediranib and Lynparza in Platinum-Sensitive Relapsed Ovarian Cancer Did Not Meet the Primary Endpoint. |
|
|
Mar 12, 2020 |
332 |
| Sentencing raider to jail 'like sending him to his death' Court: Sheriff asks why cancer drugs withheld. |
JAMES WYLLIE |
|
Mar 11, 2020 |
421 |
| Samsung Biologics partners with STCube for development and manufacture of novel target anticancer drug STT-003. |
|
|
Mar 3, 2020 |
200 |
| Samsung Biologics partners with STCube for development and manufacture of novel target anticancer drug STT-003. |
|
|
Mar 3, 2020 |
204 |
| The 10-speed cancer therapy: Bike exercise. |
|
|
Mar 3, 2020 |
1597 |
| Molecular Testing of Lung Cancers--A Summary of What, Why and How. |
Brunstein, John |
|
Mar 1, 2020 |
1461 |
| Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine. |
Jeon, Hyeonjin; Eo, Wankyu; Shim, Bumsang; Kim, Sehyun; Lee, Sookyung |
|
Mar 1, 2020 |
6013 |
| Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers. |
Lee, Su Jin; Hong, Jung Yong; Kim, Kyung; Kim, Kyoung-Mee; Kang, So Young; Lee, Taeyang; Kim, Seung |
|
Mar 1, 2020 |
4701 |
| Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders. |
da Costa, Thayse Pinheiro; Cheikh, Marcia Cury El-; Carneiro, Katia |
|
Mar 1, 2020 |
9588 |
| High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. |
Fushimi, Atsushi; Tabei, Isao; Fuke, Azusa; Okamoto, Tomoyoshi; Takeyama, Hiroshi |
|
Mar 1, 2020 |
3666 |
| Bellini Duct Carcinoma Misdiagnosed with Urothelial Papillary Carcinoma. |
Khoury, Joey El; Abdessater, Maher; Halabi, Rami; Nasr, Fadi; Boustany, Johnny; Kanbar, Anthony; Hac |
|
Mar 1, 2020 |
2262 |
| Ibrutinib-Induced Vasculitis in a Patient with Metastatic Colon Cancer Treated in Combination with Cetuximab. |
Chi, Jeffrey; Park, Jennifer; Saif, Muhammad Wasif |
|
Mar 1, 2020 |
2251 |
| Fatal Idiopathic Hyperammonemia after Induction Chemotherapy for Acute Myeloid Leukemia. |
Angelo, Christophe; Vincent, Marie-Francoise; Komuta, Mina; Hantson, Philippe; Straetmans, Nicole; B |
|
Mar 1, 2020 |
2701 |
| A Rare Case of Extracavitary Primary Effusion Lymphoma in the Bladder and Ureter. |
Tong, Jiankun; Jadallah, Sana; Rodgers, William H.; Jung, Gabriel; Fulman, Malvina; Swaika, Abhisek |
|
Mar 1, 2020 |
2364 |
| A Case Report with Severe Thrombocytopenia Induced by Axitinib. |
Koksal, Ulkuhan I.; Goffin, Janeiro; Lewis, Brian; Sartor, Oliver A.; Belyaeva, Elizaveta; Socola, F |
|
Mar 1, 2020 |
2552 |
| Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial. |
Demir, Atakan; Mandel, Nil Molinas; Paydas, Semra; Demir, Gokhan; Er, Ozlem; Turhal, Nazim Serdal; B |
|
Mar 1, 2020 |
2696 |
| A Remarkable Remission: Treating HMA Refractory Transforming MDS with Single-Agent Low-Dose Cytarabine Leading to an Ongoing Six-Year OS. |
Palmer, David; Jones, Lydia |
|
Mar 1, 2020 |
2182 |
| Shortage of crucial cancer drug blamed on delay to order. |
|
|
Feb 19, 2020 |
726 |
| Spectrum of preneoplastic and Neoplastic lesions of intestine in a tertiary care hospital of Karachi, Pakistan. |
Asma Shabbir, Muhammad Asif Qureshi, Saadia Akram and Talat Mirza |
|
Feb 14, 2020 |
2811 |
| Astex Pharmaceuticals Wins US Food and Drug Administration Acceptance for Review of an NDA for the Combination Oral Hypomethylating Agent Cedazuridine and Decitabine (ASTX727 or oral C-DEC), for the Treatment of MDS and CMML. |
|
|
Feb 14, 2020 |
923 |
| Volastra Therapeutics Launches with USD 12m in Seed Financing to Develop Novel Metastatic Cancer Therapies. |
|
|
Feb 12, 2020 |
380 |
| Metastatic Pancreatic Cancer Drug on Trial. |
|
|
Feb 1, 2020 |
224 |
| Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large, Canadian, multi-institutional database. |
Oake, Justin D.; Patel, Premal; Lavallee, Luke T.; Lattouf, Jean-Baptiste; Saarela, Olli; Klotz, Lau |
|
Feb 1, 2020 |
4689 |
| Switching from a gonadotropin-releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis. |
Atchia, Kaleem S.; Wallis, Christopher J.D.; Fleshner, Neil; Toren, Paul |
|
Feb 1, 2020 |
4758 |
| Antagonizing GnRH receptors: A temporary ADT salvage maneuver for prostate cancer patients experiencing PSA failure with GnRH agonist. |
Pinthus, Jehonathan |
|
Feb 1, 2020 |
719 |
| Arix Bioscience investee company Autolus publishes encouraging additional data from blood cancer drug study. |
|
|
Jan 31, 2020 |
218 |
| Genprex's tumor suppressor gene TUSC2 is a novel target and biomarker for thyroid cancer therapy, finds researchers. |
|
|
Jan 30, 2020 |
622 |
| NHS in Scotland could use drones to fly cancer drugs to patients on remote islands. |
|
|
Jan 29, 2020 |
567 |
| Exelixis Presents Results for Combination of Cabozantinib and Nivolumab With or Without Ipilimumab in Advanced Hepatocellular Carcinoma. |
|
|
Jan 27, 2020 |
733 |
| Epizyme's Tazemetostat Drug For Epithelioid Sarcoma Gets Accelerated FDA Approval. |
Neer Varshney |
|
Jan 24, 2020 |
355 |
| The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study. |
Shanthi Rexaline |
|
Jan 24, 2020 |
809 |
| Cyclica and AUM Biosciences to Partner on Developing Novel Cancer Therapies with Greater Precision and Speed, under Project Nexus. |
|
|
Jan 22, 2020 |
552 |
| T-cell discovery offers hope over 'cancer therapy' Health: Finding may lead to 'universal' treatment. |
NINA MASSEY |
|
Jan 21, 2020 |
325 |
| New T-cells 'raise prospect of universal cancer therapy'. |
Press Association |
|
Jan 21, 2020 |
641 |
| New killer T-cells raise hopes of 'universal cancer therapy'. |
MARK SMITH Health correspondent mark.smith@walesonline.co.uk |
|
Jan 21, 2020 |
843 |
| Killer immune cell discovery raises prospect of 'universal' cancer therapy. |
|
|
Jan 20, 2020 |
530 |
| Pharmacist jailed for selling opiate cancer drugs on black market. |
|
|
Jan 16, 2020 |
308 |
| Clinigen Group agrees cancer drug supply deal. |
|
|
Jan 15, 2020 |
239 |
| Salarius Pharmaceuticals CEO talks through recent achievements for its lead cancer drug candidate. |
|
|
Jan 14, 2020 |
123 |
| Faron Pharmaceuticals says cancer drug trial group has been expanded. |
|
|
Jan 14, 2020 |
330 |
| Clinigen Signs Agreement With Iovance For Supply Of Proleukin. |
|
|
Jan 14, 2020 |
224 |
| A Clinical Study of Cutaneous Manifestations in Patients on Cancer Therapy at a Tertiary Care Hospital. |
Muralidhar, Krishnakanth; Raghupathy, Roopa; Rangarajan, Sudha; Veeraraghavan, Mahalakshmi; Sundaram |
Clinical report |
Jan 13, 2020 |
2604 |
| Brave boy, 6, gets standing ovation from classmates after beating cancer; Heartbreaking scenes were pictured at St Helen Catholic School in Newbury, Ohio, after John Oliver Zippay completed his final round of chemotherapy to fight his leukemia. |
By, Bradley Jolly |
|
Jan 11, 2020 |
330 |
| China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies. |
|
|
Jan 6, 2020 |
817 |
| Study suggests new application for already known anti-cancer drugs. |
ANI |
|
Jan 5, 2020 |
534 |
| Discontinuation of free cancer drugs puts 5000 patients' life at risk Punjab govt fails to clear pending payments. |
|
|
Jan 4, 2020 |
641 |
| Clinical trial suggests halving cancer therapy. |
|
|
Jan 4, 2020 |
161 |
| Scientific study finds additional uses of anti-cancer drugs. |
ANI |
|
Jan 3, 2020 |
270 |
| PPP flays govt for POL price hike, cancer drug shortage. |
|
|
Jan 2, 2020 |
272 |
| The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe. |
Shanthi Rexaline |
|
Jan 2, 2020 |
848 |
| Innate Pharma Rallies On Acceptance Of European Regulatory Application For Leukemia Drug. |
Shanthi Rexaline |
|
Jan 2, 2020 |
281 |
| New Year Shock: HIV and Cancer Drugs Just Got Pricier Amid Widespread Price Increase. |
Dominic Nicosia |
|
Jan 1, 2020 |
303 |
| Stage IV Small Lymphocytic Lymphoma Presenting with Unilateral Vision Loss. |
Le, Christopher; Jacob, Adam; Iyengar, Devarajan; Dedousis, John; Tsompanidis, Antonios |
|
Jan 1, 2020 |
2350 |
| Overview of Colon Cancer for the Medical-Surgical Nurse. |
Moe, Linda; Bohnenkamp, Susan |
Medical condition overview |
Jan 1, 2020 |
2309 |
| Efficacy of Panobinostat for the Treatment of Multiple Myeloma. |
Eleutherakis-Papaiakovou, Evangelos; Kanellias, Nikolaos; Kastritis, Efstathios; Gavriatopoulou, Mar |
|
Jan 1, 2020 |
8809 |
| Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment? |
Bruinius, Jacob W.; Dykema, Karl J.; Noyes, Sabrina L.; Teh, Bin Tean; Lane, Brian R. |
|
Jan 1, 2020 |
3400 |
| Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection. |
Cha, Jae Hwang; Jang, Jin Seok |
|
Jan 1, 2020 |
3570 |
| Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection. |
Cha, Jae Hwang; Jang, Jin Seok |
|
Jan 1, 2020 |
3561 |
| Sporadic Medullary Thyroid Carcinoma with Paraneoplastic Cushing Syndrome. |
Pivovarova, Aleksandra I.; Patrick, Stephanie; Reddy, Punuru J. |
|
Dec 31, 2019 |
2064 |
| Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma. |
Spalart, Valerie; Legius, Barbara; Segers, Kurt; Coolen, Johan; Maes, Brigitte; Decoster, Lynn |
|
Dec 31, 2019 |
1790 |
| Unique Case Report of a Meningeal Sarcoma Arising during Ongoing Treatment for Progressing Intraparenchymal Glioma. |
Petersons, Richard A.; Kashyap, Bhavani; Pawloski, Pamala A.; Forsberg, Anna C.; Hanson, Leah R. |
|
Dec 31, 2019 |
4408 |
| Severely Disseminated Kaposi Sarcoma after ABO-Incompatible Kidney Transplantation Treated Successfully with Paclitaxel and Gemcitabine Combined with Hemodialysis. |
Bomholt, Tobias; Krarup-Hansen, Anders; Egfjord, Martin; Sorensen, Soren Schwartz; Junker, Niels |
|
Dec 31, 2019 |
1557 |
| Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer. |
Yang, Guangda; Jian, Liumeng; Lin, Xiangan; Zhu, Aiyu; Wen, Guohua |
|
Dec 31, 2019 |
5318 |
| Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer. |
Sun, Xiaowen; Gan, Lu; Na, Aru; Ge, Lingling; Chen, Baoqing; Liu, Jiaming |
|
Dec 31, 2019 |
9231 |
| Successes and Challenges for Diagnosis and Therapy of Acute Leukemia. |
Lonetti, Annalisa; Iacobucci, Ilaria; Masetti, Riccardo |
|
Dec 31, 2019 |
915 |
| Innovation in Oncology Drug Development. |
Huber, Matthew; Huber, Brian |
|
Dec 31, 2019 |
12396 |
| Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ ADR Cells. |
Chen, Zhi; Nishimura, Nobuhiro; Okamoto, Takayuki; Wada, Koichiro; Naora, Kohji |
|
Dec 31, 2019 |
5600 |
| A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction. |
Maher, Hadir M.; Almomen, Aliyah; Alzoman, Nourah Z.; Shehata, Shereen M.; Subaie, Amal Al- |
|
Dec 31, 2019 |
8744 |
| Systemic Pharmacological Approach to Identification and Experimental Verification of the Effect of Anisi Stellati Fructus Extract on Chronic Myeloid Leukemia Cells. |
Kim, Youn Sook; Suh, Su Yeon; Ahn, Yong Tae; Lee, Chul Won; Lee, Sang Yull; Ahn, Soon Cheol; An, Won |
|
Dec 31, 2019 |
7565 |
| Obesity May Boost Effectiveness of a Lung Cancer Therapy. |
|
|
Dec 30, 2019 |
490 |
| Using a Chip to Find Better Cancer Drugs. |
|
|
Dec 28, 2019 |
458 |
| Cancer drug better for fatter patients; Scientists term it 'obesity paradox'. |
LUCY THORNTON |
|
Dec 27, 2019 |
115 |
| Obesity May Up Cardiotoxicity Risk From Breast Cancer Therapy; Obesity independently associated with treatment-related cardiotoxicity in breast cancer patients. |
|
|
Dec 24, 2019 |
233 |
| Bladder Cancer Drugs Market Research Report, Industry Size, Share, Demand, Price, Top Manufacturers, Growth Analysis & Forecast to 2020 / Radiant Insights, Inc. |
|
Report |
Dec 23, 2019 |
898 |
